Transaction · 0001231589-26-000003

MAHON PAUL A

MAHON PAUL A, EVP, GC, reported a transaction classified as exercise at UNITED THERAPEUTICS Corp involving 8300.000000 shares for an estimated $1212049.00. Reported holdings after the transaction were 45081.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MEVP, GC
UTHRUNITED THERAPEUTICS Corp
Filing timeFeb 05
Trade dateFeb 05, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$478.93
Pre-filing
1mo ago +5.0%1w ago -2.3%1d ago +0.8%
Returns since
7d -0.6%30d -0.2%90d +24.6%180d +8.3%1y +7.6%

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2026-02-05Filed 211 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001231589-26-000003
Common Stock
Transaction date
Feb 05, 2026
Filed Feb 05, 2026, 09:31 PM · 0d delay
Shares
8.30k sh
$14.6k per share
Estimated value
$121M
Computed from shares × price
Holdings after
45.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & GENERAL COUNSEL

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $480.21 to $481.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  3. F3

    This transaction was executed in multiple trades at prices ranging from $481.29 to $482.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  4. F4

    This transaction was executed in multiple trades at prices ranging from $482.29 to $483.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  5. F5

    This transaction was executed in multiple trades at prices ranging from $483.32 to $484.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  6. F6

    This transaction was executed in multiple trades at prices ranging from $484.32 to $485.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  7. F7

    This transaction was executed in multiple trades at prices ranging from $485.34 to $485.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

Original filing · 0001231589-26-000003
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR